US-Listed Biological Products, (No Diagnostic Substances) — Total Assets Percentiles, FY 2021

Population: 201 US-listed companies (SIC 2836), fiscal year 2021; fiscal year ends 2021-06-30 to 2022-04-30.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile	$26.4M
25th percentile	$71.7M
Median	$190.8M
75th percentile	$454.0M
90th percentile	$1.0B
Mean	$1.3B
Minimum	$0
Maximum	$68.0B

Methodology & sources
Total Assets as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2021 = fiscal years ending 2021-06-01 to 2022-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-03.

Evidence samples

Latest Total Assets percentiles (live) · All Biological Products, (No Diagnostic Substances) benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-2836/total-assets/2021